Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
D000230:Adenocarcinoma / Q000188:drug therapy*; D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy; D000477:Alkylating Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003510:Cyclohexanes / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D013997:Time Factors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009607:Nitrosourea Compounds